Dates: 11 – 15 October 2011 Location: Montreal, Quebec
The ICHG is the foremost meeting of the world human genetics community. As collaborative science increasingly crosses geographic boundaries, and the variation in the world’s population is better understood, the interaction among scientists becomes more vital and vibrant. In 2011, the ICHG will be the major focal point and platform for the world’s most exciting research.
Dates: 12 – 16 November 2011 Location: San Francisco, CA
This conference is the thriving offspring of the original EORTC-NCI meetings on drug discovery and development. The AACR partnership began in 1999, in response to the need for more frequent meetings to keep pace with the rapid advancement of molecular biology and genetics, and the consequent emergence of many new targets for cancer therapeutics. Our collaboration ensures that new information is exchanged regularly, so that everyone in the field keeps current with the latest developments.
Dates: 12 – 16 November 2011 Location: Washington, DC
Each year SfN provides the premier venue for neuroscientists to share research findings. By attending lectures, symposia, and workshops, meeting attendees experience the most exciting and cutting-edge research the field of neuroscience has to offer. SfN's annual meeting draws diverse attendees from all over the world.
Dates: 3-7 December 2011 Location: Denver, CO
As the premier international meeting in the field of cell biology, the ASCB Annual Meeting is intended for scientists and students in academia, industry, government, and higher education. With opportunities to learn about the latest research and network with peers, the ASCB Annual Meeting appeals to the diverse interests of the international cell biology community.
Dates: 6 – 10 December 2011 Location: San Antonio, TX
The 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium is presented by Cancer Therapy & Research Center at UT Health Science Center San Antonio, the American Association for Cancer Research, and Baylor College of Medicine. By combining their respective strengths, the symposium encompasses the full spectrum of breast cancer research and facilitates the rapid transition of new knowledge into improved care for breast cancer patients.